Skip to main content
Caplight Logo









DexCare

DexCare

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://dexcare.com/

Last Round

Series C

Jun 21, 2023

Total Funding Raised

$145M

Company Overview

DexCare is a healthcare technology company that offers an access optimization platform to intelligently orchestrate health system capacity and digital demand across all lines of care.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

care orchestrationdigital front doorpatient navigationpatient accessscheduling optimizationelectronic health recordsEHRhealth techhealthcare SaaSsmall language modelsSLMAI schedulingprovider capacityhealthcare workflow automationpatient demand management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DexCare Comparables

Compare DexCare with similar companies based on industry and business-model similarity.

DexCare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Notable
83%
Luma Health
82%
Health Catalyst
81%

DexCare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 21, 2023
Series BJan 13, 2022
Series AMar 22, 2021

Key People

Founding team and executive leadership

Matthew Blosl

Chief Executive Officer (CEO)

Executive Team

Chris Carruthers

Chief Innovation Officer, VP of Product, VP of Solutions

Executive Team

DexCare Investors

Notable investors and investment history

DexCare investors
InvestorRounds
Define VenturesSeries C, Series B, Series A
Kaiser Permanente VenturesSeries C, Series A, Series B
Frist Cressey VenturesSeries A, Series B, Series C
ICONIQ GrowthSeries C
Allumia VenturesSeries C, Series A, Series B
SpringRock VenturesSeries C, Series A, Series B
Define VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 28, 2026

    Ravi Doddivaripalli joins as the new CTO.

  • Dec 15, 2025

    Rakshay Jain joins as Chief Product Officer.

DexCare Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DexCare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DexCare's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range138
Year Founded2021
Last FundingJun 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?